Claudia Homorogan

Mrs. Claudia Homorogan

Victor Babes University of Medicine and Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Life
Verified
Journal Article
Open access
PDF file
SSStefan Iulian Stanciugelu
Stefan Iulian Stanciugelu
Claudia HomoroganClaudia Homorogan
Claudia Homorogan
CSCosmin Selaru
Cosmin Selaru
JPJenel Marian Patrascu
Jenel Marian Patrascu
JPJenel Marian Jr Patrascu
Jenel Marian Jr Patrascu
CMCatalin Marian
Catalin Marian
Osteoarthritis (OA) is one of the most prevalent degenerative joint diseases in older adults and a leading cause of disability. Recent research studies have evidenced the importance of mi-croRNAs (miRs) in the pathogenesis of OA. In the present review, we focused on current literature findings on dysregulated miRs involved in the pathophysiology of OA. From the 35 case-control studies including OA patients compared to healthy controls, a total of 54 human miRs were identified to be dysregulated in OA. In total, 41 miRs were involved in the pathophysiological processes of OA, including apoptosis, inflammation, and proliferation, having either a protective or a progressive role in OA. The discovery of altered miR levels in OA patients compared to healthy controls determines a better understanding of the molecular mechanisms involved in the pathophysiology of OA and could open novel horizons in the field of orthopedics.

7 April 2021 in Journal of International Medical Research
Verified
Journal Article
Open access
PDF file
Claudia HomoroganClaudia Homorogan
Claudia Homorogan
VEVirgil Radu Enatescu
Virgil Radu Enatescu
DNDiana Nitusca
Diana Nitusca
AMAnca Marcu
Anca Marcu
ESEdward Seclaman
Edward Seclaman
CMCatalin Marian
Catalin Marian
Objective: Major depressive disorder (MDD) is a recurrent disorder with an increasing incidence. Alterations in key signaling pathways of the nervous system, such as the Wnt and MAPK pathways, mediated through microRNAs (miRNAs) provide crucial information regarding the etiopathology of MDD. We aimed to analyze whether the heterogeneity of literature findings regarding differential expression of miRNAs in the blood could arise from their different distributions among blood compartments. Methods: We performed a pilot study analyzing the differential expression of miR-26a, miR-494, miR-30c, miR-93, and miR-101 and investigated their levels in white blood cells, total plasma (TP), exosomes from plasma, and exosome depleted plasma (EDP) in patients with MDD before and after antidepressant treatment with escitalopram and in healthy controls. Results: MiR-494 was more abundant in EDP, and miR-26a and miR-30c were predominantly more abundant in TP relative to other blood compartments. Moreover, miR-30c, miR-101, and miR-26a, were significantly downregulated in TP of patients with MDD compared with controls. After antidepressant treatment, only miR-494 was significantly differently expressed in EDP. Conclusions: This proof-of-principle study suggests that identifying the miRNA abundance in different blood compartments is crucial for biomarker development and could enrich the current knowledge regarding MDD pathophysiology.

11 October 2021 in Life
Verified
Journal Article
Open access
PDF file
Claudia HomoroganClaudia Homorogan
Claudia Homorogan
DNDiana Nitusca
Diana Nitusca
ESEdward Seclaman
Edward Seclaman
VEVirgil Radu Enatescu
Virgil Radu Enatescu
CMCatalin Marian
Catalin Marian
Major depressive disorder (MDD) is a recurrent debilitating illness that represents a major health burden due to its increasing worldwide prevalence, unclear pathological mechanism, nonresponsive treatment, and lack of reliable and specific diagnostic biomarkers. Recently, microRNA species (miRs) have gained particular interest because they have the ability to post-transcriptionally regulate gene expression by modulating mRNA stability and translation in a cohesive fashion. By regulating entire genetic circuitries, miRs have been shown to have dysregulated expression levels in blood samples from MDD patients, when compared to healthy subjects. In addition, antidepressant treatment (AD) also appears to alter the expression pattern of several miRs. Therefore, we critically and systematically reviewed herein the studies assessing the potential biomarker role of several candidate miRs for MDD, as well as treatment response monitoring indicators, in order to enrich the current knowledge and facilitate possible diagnostic biomarker development for MDD, which could aid in reducing both patients’ burden and open novel avenues toward a better understanding of MDD neurobiology.

27 February 2017
Verified
Conference Paper
Closed access
Claudia HomoroganClaudia Homorogan
Claudia Homorogan

14 February 2022 in Biomedical Journal of Scientific & Technical Research
Verified
Journal Article
Open access
PDF file
Claudia HomoroganClaudia Homorogan
Claudia Homorogan
Due to the increasing lifespan around the globe, musculoskeletal disorders like Osteoarthritis (OA) tend to have a higher prevalence comparing to the past decades...